Skip to main content

Affeldt Eric's Form 4/A amendment

Amended

Strata Critical Medical, Inc. (SRTA) · filed Dec 3, 2024

Accession no.
0001779128-24-000140
Filed
Dec 3, 2024
Rule 10b5-1 plan
Not checked
Original filed
Nov 14, 2023

This filing lists no transactions. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $160.0K.

This amendment restates part of 0001779128-23-000123 (filed Nov 14, 2023). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Affeldt EricCIK 0001493978Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

This filing has no transactions of this kind.

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001779128-23-000123 (filed Nov 14, 2023).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001779128-23-000123
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 13, 2023Class A common stock, $0.0001 par value per sharePPurchaseAcquired+50,000$3.20F1+$160,00060,000Indirect

Footnotes on the original

The footnotes that the prices of these transactions refer to on the original filing.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.17 to $3.20, inclusive. The reporting person undertakes to provide to Blade Air Mobility, Inc., any security holder of Blade Air Mobility, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Referenced by the price of 1 transaction in Table I.

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

On November 14, 2023, the reporting person filed a Form 4 which inadvertently reported in column 5 of Table I that, following the purchase of 50,000 shares, the reporting person indirectly beneficially owned 60,000 shares through the Eric L Affeldt Living Trust (the "Trust"), for which the reporting person served as the trustee, and directly beneficially owned 502,854 shares. In fact, as reported in this amendment, the reporting person indirectly beneficially owned 465,250 shares through the Trust and beneficially owned 87,604 shares. As a result, the original Form 4 mistakenly overstated the reporting person's beneficial ownership by 10,000 shares in the aggregate.

F2

The reported securities are held by the Eric L Affeldt Living Trust for which the Reporting Person serves as the trustee.

Read the full filing on SEC EDGAR (opens in a new tab)